Investigating the efficacy of osimertinib and crizotinib in phase 3 clinical trials on anti-cancer treatment-induced cardiotoxicity: are real-world studies the way forward?

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners(2023)

引用 2|浏览5
暂无评分
摘要
Although phase 3 clinical trials play an important role in understanding the effectiveness and give insights on side-effect profiles, real-world studies can show the real risk of cardiotoxicity more accurately and realistically.
更多
查看译文
关键词
Cardiotoxicity,anti-cancer treatment,cardio-oncology,real-world evidence,real-world experience
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要